Study S002084

Efficacy and Safety of Semaglutide in Weight Reduction in Overweight or Obese Bangladeshi Adults With or Without Type 2 Diabetes Mellitus

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT06616961
Study type: INTERVENTIONAL
Phase: PHASE3
Masking: NONE
Status: NOT_YET_RECRUITING
Enrollment: 480
Start: 2024-11-01
Primary completion: 2025-02
Lead sponsor: Popular Medical College Hospital
Conditions: Obesity; Type 2 Diabetes Mellitus (T2DM)
Interventions: DRUG:Semaglutide Pen
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Body Weight (kg) [26 weeks]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.